The Frequency of Multidrug-Resistant Tuberculosis Patient who have History of Tuberculosis, HIV, and Diabetes Mellitus at Dr. Soetomo General Academic Hospital
Downloads
Introduction: The main causes of MDR TB include interperson transmission and TB treatment failure. In addition to TB, HIV and diabetes mellitus may raise the risk of TB MDR. To determine the TB MDR risk factors, it's critical to understand the prevalence of TB MDR patients with TB, HIV, and diabetes mellitus histories.
Methods: This study is an observational descriptive study with a retrospective design. The sample for this study was all patients from the TB and MDR-TB polyclinic at Dr. Soetomo General Academic Hospital, Surabaya, in January 2020–December 2020 who met the inclusion criteria. The data obtained were analyzed descriptively.
Results: There were 72 patients who met the criteria: there were 26 patients who have a history of TB, 15 patients who only have a history of diabetes mellitus, 2 patients who only have a history of HIV, 27 patients who have a history of TB with diabetes mellitus, and 2 patients who have a history of TB with HIV.
Conclusion: The data could support the theory of an association between MDR-TB with TB, HIV, and diabetes mellitus and increase the awareness of primary MDR TB cases with history of HIV and diabetes mellitus.
Baya B, Achenbach CJ, Kone B, et al. 2019. Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali. International Journal of Infectious Disease 81:149–155. https://doi.org/10.1016/j.ijid.2019.02.004.
Echazarreta A, Zerbini E, De Sandro J, et al. Tuberculosis and comorbidities in urban areas in Argentina. A gender and age perspective. Biomedica 38(2):180–188. https://doi.org/10.7705/biomedica.v38i0.390.
Elduma AH, Mansournia MA, Foroushani AR, et al. 2019. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study. Epidemiology and Health 41:e2019014. https://doi.org/10.4178/epih.e2019014.
Li D, He W, Chen B, et al. 2017. Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings. PLoS One 12(6). https://doi.org/10.1371/journal.pone.0176354.
Lv XT, Lu XW, Shi XY, et al. 2017. Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China. Journal of International Medical Research 45(6):1779–1786. https://doi.org/10.1177/0300060516687429.
McIvor A, Koornhof H, Kana BD. 2017. Relapse, re-infection and mixed infections in tuberculosis disease. Pathogens and Disease 75(3). https://doi.org/10.1093/femspd/ftx020.
Ministry of Health Republic of Indonesia. 2021. Dashboard Tuberkulosis Indonesia 2020 [serial online]. Available at https://tbindonesia.or.id/pustaka-tbc/dashboard-tb/. Accessed on 1 December 2021.
National Institutes of Health (NIH). 2019. HIV and Tuberculosis (TB) [serial online]. [citied 2020 April 30]. Available at https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-and-tuberculosis-tb. Accessed on 30 April 2020.
Pradipta IS, Forsman LD, Bruchfeld J, et al. 2018. Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis. Journal of Infection 77(6):469-478. https://doi.org/10.1016/j.jinf.2018.10.004.
Rumende CM. 2018. Risk factors for multidrug-resistant tuberculosis. Acta Medica Indonesiana 50(1):1–2.
Saktiawati AMI and Subronto YW. 2018. Influence of diabetes mellitus on the development of multi drug resistant-tuberculosis in Yogyakarta. Acta Medica Indonesiana 50(1):11–17.
Singh A, Prasad R, Balasubramanian V, et al. 2020. Drug-resistant tuberculosis and HIV infection: current perspectives. HIV AIDS (Auckl) 12:9–31. https://doi.org/10.2147/HIV.S193059.
Song WM, Li YF, Ma X, et al. 2019. Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018. Respiratory Research 20. https://doi.org/10.1186/s12931-019-1199-3.
Sultana ZZ, Hoque FU, Beyene J, et al. 2021. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC Infectious Diseases 21. https://doi.org/10.1186/s12879-020-05749-2.
Tegegne BS, Mengesha MM, Teferra AA, et al. 2018. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Systematic Reviews 7. https://doi.org/10.1186/s13643-018-0828-0.
Waseem N, Waqas U, Rauf M, et al. 2021. The prevalence of multidrug resistant tuberculosis (MDR-TB) in different age groups keeping Gene-Xpert MTB/RIF as a gold standard technique. EAS Journal of Parasitology and Infectious Diseases 3(1):6–11. https://doi.org/10.36349/easjpid.2021.v03i01.002.
World Health Organization. 2018. Tuberculosis: Multidrug-resistant Tuberculosis (MDR-TB) [serial online]. Available at https://www.who.int/news-room/questions-and-answers/item/tuberculosis-multidrug-resistant-tuberculosis-(mdr-tb). Accessed on 6 January 2022.
World Health Organization. 2021a. HIV/AIDS [serial online]. Available at https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed 4 January 2022.
World Health Organization. 2021b. Diabetes. Available at https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed on 6 January 2022.
Copyright (c) 2023 Marsha Zahrani, Rebekah J. Setiabudi, Helmia Hasan, Manik Retno Wahyunitisari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) Author
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
